Erratum: Stepwise acetyltransferase association and histone acetylation at the Myod1 locus during myogenic differentiation (Scientific Reports (2013) 3 (2390) DOI: 10.1038/srep02390));Stepwise acetyltransferase association and histone acetylation at the Myod1 locus during myogenic differentiation

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Hamed, Munerah ^a   Khilji, Saadia ^a   Chen, Jihong ^a   Li, Qiao ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE ACETYLTRANSFERASE; MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN;

ACETYLATION; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; FIBROBLAST; GENETICS; MOUSE; MYOBLAST; PHYSIOLOGY; REGULATORY SEQUENCE;

ACETYLATION; ANIMALS; CELL DIFFERENTIATION; CELL LINE; FIBROBLASTS; HISTONE ACETYLTRANSFERASES; HISTONES; MICE; MYOBLASTS; MYOD PROTEIN; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 84883004255     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05673     Document Type: Erratum

References (32)

1. Heintzman, N. D. & Ren, B. Finding distal regulatory elements in the human genome. Curr Opin Genet Dev 19, 541-9 (2009).
2. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. & Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-9 (1996). (Pubitemid 26404293)
3. Bedford, D. C. & Brindle, P. K. Is histone acetylation the most important physiological function for CBP and p300? Aging (Albany NY) 4, 247-55 (2012).
4. Heintzman, N. D. et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39, 311-8 (2007). (Pubitemid 46328487)
5. Blow,M. J. et al.ChIP-Seq identification of weakly conserved heart enhancers. Nat Genet 42, 806-10 (2010).
6. Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107, 21931-6 (2010).
7. Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-83 (2011).
8. Heintzman, N. D. et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-12 (2009).
9. Schwartz, Y. B. & Pirrotta, V. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 8, 9-22 (2007). (Pubitemid 46006046)
10. Chen, J. & Li, Q. Life and death of transcriptional co-activator p300. Epigenetics 6, 957-61 (2011).
11. Roth, J. F. et al. Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD andMyf5. Embo J 22, 5186-96 (2003).
12. Tapscott, S. J. The circuitry of amaster switch: Myod and the regulation of skeletal muscle gene transcription. Development 132, 2685-95 (2005). (Pubitemid 40932860)
13. Francetic, T. & Li, Q. Skeletal myogenesis and Myf5 activation. Transcription 2, 109-14 (2011).
14. Goldhamer, D. J. et al. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development 121, 637-49 (1995).
15. Kablar, B. et al. Myogenic determination occurs independently in somites and limb buds. Dev Biol 206, 219-31 (1999). (Pubitemid 29100477)
16. Tapscott, S. J., Lassar, A. B. &Weintraub, H. A novel myoblast enhancer element mediates MyoD transcription. Mol Cell Biol 12, 4994-5003 (1992).
17. Asakura, A., Lyons, G. E. & Tapscott, S. J. The regulation of MyoD gene expression: conserved elements mediate expression in embryonic axial muscle. Dev Biol 171, 386-98 (1995).
18. Charge, S. B., Brack, A. S., Bayol, S. A. & Hughes, S. M. MyoD- and nervedependent maintenance of MyoD expression in mature muscle fibres acts through the DRR/PRR element. BMC Dev Biol 8, 5 (2008).
19. Francetic, T. et al. Regulation of Myf5 early enhancer by histone acetyltransferase p300 during stem cell differentiation. Mol Biol 1, 103 (2012).
20. Yang, J. H. et al. Myogenic transcriptional activation of MyoD mediated by replication-independent histone deposition. Proc Natl Acad Sci U S A 108, 85-90 (2011).
21. Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H. & Nakatani, Y. A p300/ CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324 (1996). (Pubitemid 26260451)
22. Puri, P. L. et al. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1, 35-45 (1997). (Pubitemid 127376391)
23. Sartorelli, V. et al. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell 4, 725-34 (1999).
24. Silberstein, L., Webster, S. G., Travis, M. & Blau, H. M. Developmental progression of myosin gene expression in cultured muscle cells. Cell 46, 1075-81 (1986). (Pubitemid 17182731)
25. Balasubramanyam, K., Swaminathan, V., Ranganathan, A. & Kundu, T. K. Small molecule modulators of histone acetyltransferase p300. J Biol Chem 278, 19134-40 (2003). (Pubitemid 36799302)
26. Balasubramanyam, K. et al. Curcumin, a novel p300/CREB-binding proteinspecific inhibitor of acetyltransferase, represses the acetylation of histone/ nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279, 51163-71 (2004).
27. Morimoto, T. et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 118, 868-78 (2008). (Pubitemid 351364595)
28. St-Germain, J. R., Chen, J. & Li, Q. Involvement of PML nuclear bodies in CBP degradation through the ubiquitin-proteasome pathway. Epigenetics 3, 342-9 (2008).
29. Higazi, A., Abed, M., Chen, J. & Li, Q. Promoter context determines the role of proteasome in ligand-dependent occupancy of retinoic acid responsive elements. Epigenetics 6, 202-211 (2011).
30. Liu, Y., Chu, A., Chakroun, I., Islam, U. & Blais, A. Cooperation between myogenic regulatory factors and SIX family transcription factors is important for myoblast differentiation. Nucleic Acids Res 38, 6857-71 (2010).
31. Chen, J., St-Germain, J. R.&Li,Q. B56 Regulatory Subunit of Protein Phosphatase 2A Mediates Valproic Acid-Induced p300 Degradation. Mol Cell Biol 25, 525-32 (2005). (Pubitemid 40096575)
32. Le May, M. et al. Contribution of Retinoid X Receptor Signaling to the Specification of Skeletal Muscle Lineage. J Biol Chem 286, 26806-12 (2011).